Both patients who developed EBV-associated gastric cancer had received abatacept, a CTLA-4-Ig-fusion-protein, which is expected to improve especially the gastrointestinal symptoms in adult autoimmune enteropathy but could raise EBV serum levels (13). The gene discussed is CTLA4; the disease is gastric cancer.